Skip to main content

What the FDA labels say about taking them together

Maraviroc and ritonavir

Maraviroc's FDA label of September 26, 2022 names ritonavir in its drug interactions section, and ritonavir's label names maraviroc too. The maraviroc label: “Coadministration with CYP3A inhibitors, including protease inhibitors, will increase the concentration of SELZENTRY.”

Check it at the source: the maraviroc FDA label on DailyMed (effective September 26, 2022, ViiV Healthcare Company); the ritonavir FDA label on DailyMed (effective July 23, 2026, AbbVie Inc.).

What does the maraviroc label say about ritonavir?

Maraviroc label, drug interactions

Coadministration with CYP3A inhibitors, including protease inhibitors (except tipranavir/ritonavir), will increase the concentration of SELZENTRY.

Source: FDA drug label (SELZENTRY), ViiV Healthcare Company, effective September 26, 2022 (SPL set 46f30ac5-c96b-429e-976d-8c5ee1c0761b), via openFDA; the full label on DailyMed

What does the ritonavir label say about maraviroc?

Ritonavir label, drug interactions

Concomitant Drug Class/Drug Name: HIV-1 CCR5 – antagonist: maraviroc; Effect on Concentration of Ritonavir or Concomitant Drug: ↑ maraviroc; Clinical Comment: See the complete prescribing information for maraviroc for details on co-administration of maraviroc and ritonavir-containing protease inhibitors.

Source: FDA drug label (Norvir), AbbVie Inc., effective July 23, 2026 (SPL set 2849298e-de6e-47bb-8194-56e075b33fc3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

8Maraviroc generic labelers
7Ritonavir generic labelers
MaravirocRitonavir
Labeled forHIVHIV
Boxed warningYesYes
Pharmacy cost (NADAC)$9.15 per tablet 150 mg tablet$0.607 per tablet 100 mg tablet
Shortage nowA presentation being discontinuedA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?